Full Text Available
Note: Clicking the button above will open the full text document at the original institutional repository in a new window.
Respiratory Syncytial Virus Immunization Coverage Among Infants Through Receipt of Nirsevimab Monoclonal Antibody or Maternal Vaccination - United States, October 2023-March 2024
Saved in:
| Published in: | MMWR Morbidity and Mortality Weekly Report |
|---|---|
| Format: | Online Article RSS Article |
| Published: |
2025
|
| Subjects: | |
| Tags: |
No Tags, Be the first to tag this record!
|
| _version_ | 1864030189187497989 |
|---|---|
| collection | WordPress RSS FRELIP Feed Integration |
| container_title | MMWR Morbidity and Mortality Weekly Report |
| description | |
| discipline_display | Social Sciences |
| discipline_facet | Social Sciences |
| format | Online Article RSS Article |
| genre | Journal Article |
| id | rss_article:31972 |
| institution | FRELIP |
| journal_source_facet | MMWR Morbidity and Mortality Weekly Report |
| publishDate | 2025 |
| publishDateSort | 2025 |
| record_format | rss_article |
| spellingShingle | Respiratory Syncytial Virus Immunization Coverage Among Infants Through Receipt of Nirsevimab Monoclonal Antibody or Maternal Vaccination - United States, October 2023-March 2024 — — — — — Demography and Population Studies Psychology Social Sciences |
| sub_discipline_display | Psychology |
| sub_discipline_facet | Psychology |
| subject_display | — — — — — Demography and Population Studies Psychology Social Sciences — — — — — Demography and Population Studies Psychology Social Sciences |
| subject_facet | — — — — — Demography and Population Studies Psychology Social Sciences |
| title | Respiratory Syncytial Virus Immunization Coverage Among Infants Through Receipt of Nirsevimab Monoclonal Antibody or Maternal Vaccination - United States, October 2023-March 2024 |
| title_auth | Respiratory Syncytial Virus Immunization Coverage Among Infants Through Receipt of Nirsevimab Monoclonal Antibody or Maternal Vaccination - United States, October 2023-March 2024 |
| title_full | Respiratory Syncytial Virus Immunization Coverage Among Infants Through Receipt of Nirsevimab Monoclonal Antibody or Maternal Vaccination - United States, October 2023-March 2024 |
| title_fullStr | Respiratory Syncytial Virus Immunization Coverage Among Infants Through Receipt of Nirsevimab Monoclonal Antibody or Maternal Vaccination - United States, October 2023-March 2024 |
| title_full_unstemmed | Respiratory Syncytial Virus Immunization Coverage Among Infants Through Receipt of Nirsevimab Monoclonal Antibody or Maternal Vaccination - United States, October 2023-March 2024 |
| title_short | Respiratory Syncytial Virus Immunization Coverage Among Infants Through Receipt of Nirsevimab Monoclonal Antibody or Maternal Vaccination - United States, October 2023-March 2024 |
| title_sort | respiratory syncytial virus immunization coverage among infants through receipt of nirsevimab monoclonal antibody or maternal vaccination - united states, october 2023-march 2024 |
| topic | — — — — — Demography and Population Studies Psychology Social Sciences |
| url | https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=760099 |